Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

107.04
+0.04000.04%
Volume:372.27K
Turnover:39.93M
Market Cap:12.15B
PE:31.65
High:108.17
Open:107.96
Low:106.34
Close:107.00
52wk High:111.15
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:0.32
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:84.64
PE(LYR):41.81

Loading ...

Aug 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 26, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 25, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2023

Correspondence

Form CORRESP - Correspondence
Jun 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
Apr 18, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Major Issues Report

8-K - Current report